Clinical Presentation and Outcomes of Antineutrophil Cytoplasmic Autoantibody-Negative Pauci-Immune Glomerulonephritis.
抗中性球胞漿抗體陰性少免疫性腎小球腎炎的臨床表現與預後
Kidney Int Rep 2025-06-09
Venous Thromboembolism Prevention in Nephrotic Syndrome: The Role of Aspirin, Vitamin K Antagonists, and Direct Oral Anticoagulants.
腎病症候群中靜脈血栓栓塞預防:Aspirin、維生素K拮抗劑與直接口服抗凝劑的角色
Kidney Int Rep 2025-06-09
Kidney Transplantation Improves Survival in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides With End-Stage Kidney Disease.
腎臟移植可改善抗中性球胞漿抗體相關血管炎(Antineutrophil Cytoplasmic Antibody-Associated Vasculitides)末期腎病患者的存活率
Kidney Int Rep 2025-06-09
對於因 ANCA 血管炎導致末期腎病的病人,腎臟移植比持續透析明顯提升存活率。法國研究顯示,移植後十年存活率達 72%,而透析僅 28%。因此,及早評估並增加移植機會對這類病人非常重要。
相關文章PubMedDOI推理
Corrigendum to "A Targeted Release Capsule of Lanthanum Carbonate: A New Efficient Cheap Treatment for Primary Hyperoxalurias" [Volume 10, Issue 2, February 2025, Pages 503-515].
「更正啟事:『Lanthanum Carbonate 標靶釋放膠囊:原發性高草酸尿症的新型高效低價治療方式』(第10卷,第2期,2025年2月,頁503-515)」
Kidney Int Rep 2025-06-09
這是一則針對 DOI 10.1016/j.ekir.2024.11.020 文章的更正通知,主要是修正或補充原文內容。詳細更正內容請參考官方公告或出版商網站。
相關文章PubMedDOI推理
Persistent B Cell Depletion After Rituximab for Autoimmune and Glomerular Diseases: A Case Series.
Rituximab 治療自體免疫與腎小球疾病後持續性 B 細胞耗竭:病例系列報告
Kidney Int Rep 2025-06-09
Corrigendum to "PREGNANCY AS A WINDOW TO CURRENT AND FUTURE KIDNEY HEALTH-AN OPPORTUNITY" [Volume 10, Issue 3, March 2025, Pages 645-649].
「PREGNANCY AS A WINDOW TO CURRENT AND FUTURE KIDNEY HEALTH-AN OPPORTUNITY」[第10卷,第3期,2025年3月,第645-649頁]之更正啟事
Kidney Int Rep 2025-06-09
Early Determination of Tacrolimus Concentration-Dose Ratio Identifies Risk of Allograft Loss in Kidney Transplantation.
早期測定 Tacrolimus 濃度劑量比可識別腎臟移植中移植物喪失的風險
Kidney Int Rep 2025-06-09
Corrigendum to "The Bromodomain and Extraterminal Protein Inhibitor Apabetalone Ameliorates Kidney Injury in Diabetes by Regulating Cholesterol Accumulation and Modulating the Gut Microbiota" [Volume 10, Issue 2, February 2025, Pages 522-534].
「更正啟事:'Bromodomain and Extraterminal Protein Inhibitor Apabetalone 透過調節膽固醇累積及腸道菌相,改善糖尿病腎損傷'【第10卷,第2期,2025年2月,522-534頁】」
Kidney Int Rep 2025-06-09